Back to Search
Start Over
Newer Treatments for Mood and Anxiety Disorders.
- Source :
-
The Medical clinics of North America [Med Clin North Am] 2024 Sep; Vol. 108 (5), pp. 911-921. Date of Electronic Publication: 2024 Apr 21. - Publication Year :
- 2024
-
Abstract
- For more than 20 years, the mainstay of pharmacologic treatment for depression and anxiety disorders has been serotonin reuptake inhibitors and selective serotonin and norepinephrine reuptake inhibitors. There are newer medications, many with novel mechanisms of action, that have come to market; however, first-line treatments remain the same. There are now more robust data on the use of various augmentation agents in the treatment of major depressive disorder providing better recommendations for use by the primary care provider. Data to support the use of psychedelic-assisted psychotherapy in the treatment of mood and anxiety disorders are not robust enough to recommend generalized use at this time.<br />Competing Interests: Disclosure Neither Dr J. Markman nor Dr H. Combs have any financial conflicts of interest or funding sources to declare.<br /> (Published by Elsevier Inc.)
- Subjects :
- Humans
Psychotherapy methods
Anti-Anxiety Agents therapeutic use
Serotonin and Noradrenaline Reuptake Inhibitors therapeutic use
Depressive Disorder, Major therapy
Depressive Disorder, Major drug therapy
Anxiety Disorders therapy
Anxiety Disorders drug therapy
Mood Disorders therapy
Mood Disorders drug therapy
Selective Serotonin Reuptake Inhibitors therapeutic use
Antidepressive Agents therapeutic use
Subjects
Details
- Language :
- English
- ISSN :
- 1557-9859
- Volume :
- 108
- Issue :
- 5
- Database :
- MEDLINE
- Journal :
- The Medical clinics of North America
- Publication Type :
- Academic Journal
- Accession number :
- 39084841
- Full Text :
- https://doi.org/10.1016/j.mcna.2024.03.006